These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32742760)

  • 1. Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.
    Kim S; Kang-Mieler JJ; Liu W; Wang Z; Yiu G; Teixeira LBC; Mieler WF; Thomasy SM
    Transl Vis Sci Technol; 2020 Feb; 9(3):30. PubMed ID: 32742760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.
    Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.
    Liu W; Lee BS; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2019 Mar; 44(3):264-274. PubMed ID: 30295090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.
    Osswald CR; Kang-Mieler JJ
    Curr Eye Res; 2016 Sep; 41(9):1216-22. PubMed ID: 26764892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System.
    Liu W; Tawakol AP; Rudeen KM; Mieler WF; Kang-Mieler JJ
    Transl Vis Sci Technol; 2020 Oct; 9(11):13. PubMed ID: 33117605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.
    Rudeen KM; Liu W; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2022 Jul; 47(7):1034-1042. PubMed ID: 35343355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates.
    Kiss S; Oresic Bender K; Grishanin RN; Hanna KM; Nieves JD; Sharma P; Nguyen AT; Rosario RJ; Greengard JS; Gelfman CM; Gasmi M
    Transl Vis Sci Technol; 2021 Jan; 10(1):34. PubMed ID: 33532145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Bioavailability of Complete and Half-Dose Intravitreal Ziv-Aflibercept in an Experimental Model: Contralateral Eye Study.
    Lashay A; Delrish E; Ashrafi E; Movassat M; Asadi-Amoli F; Dinarvand R; Abrishami M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):785-790. PubMed ID: 31877224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes.
    Julien S; Biesemeier A; Taubitz T; Schraermeyer U
    Br J Ophthalmol; 2014 Jun; 98(6):813-25. PubMed ID: 24457369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes.
    Niwa Y; Kakinoki M; Sawada T; Wang X; Ohji M
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6501-5. PubMed ID: 26447985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
    Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina.
    Lee S; Hong HK; Song JS; Jeong SI; Chung JY; Woo SJ; Park KD
    Acta Biomater; 2023 Nov; 171():273-288. PubMed ID: 37739248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual and anatomic outcomes of aflibercept treatment in treatment-naive patients with neovascular age-related macular degeneration; real-life data over 24 months.
    Makri OE; Tsapardoni FN; Tsekouras IK; Lagogiannis AP; Chairas N; Pallikari A; Pagoulatos DD; Georgakopoulos CD
    Hell J Nucl Med; 2019; 22 Suppl 2():55-62. PubMed ID: 31802046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion.
    Giuffrè C; Cicinelli MV; Marchese A; Coppola M; Parodi MB; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):787-793. PubMed ID: 31897703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments.
    Rusu IM; Deobhakta A; Yoon D; Lee M; Slakter JS; Klancnik JM; Thompson D; Freund KB
    Retina; 2014 Nov; 34(11):2161-6. PubMed ID: 25072648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
    Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J
    Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical investigations of intravitreal ziv-aflibercept.
    de Oliveira Dias JR; Badaró E; Novais EA; Colicchio D; Chiarantin GM; Matioli MM; Verna C; Penha FM; Barros NM; Meyer CH; Farah ME; Rodrigues EB
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):577-84. PubMed ID: 25423640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits.
    Hu CC; Chiu YC; Chaw JR; Chen CF; Liu HW
    Technol Health Care; 2019; 27(S1):153-163. PubMed ID: 31045535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cone-driven functions after intravitreal aflibercept injections in patients with age-related macular degeneration.
    Nishimura T; Machida S; Hara Y
    Doc Ophthalmol; 2020 Oct; 141(2):137-147. PubMed ID: 32100141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.